# Enpicom

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/enpicom

- Industry: Software
- Headquarters: 's-Hertogenbosch, Netherlands
- Website: www.enpicom.com
- Total disclosed funding: $1.4M
- Latest round: Series A (Mar 5, 2019)
- Investors on record: 3

## About

Enpicom BV is a bioinformatics company focused on accelerating biologics discovery through a unified platform that automates bioinformatics workflows and integrates advanced machine learning frameworks.Founded in 2015 in 's-Hertogenbosch, Netherlands, Enpicom BV specializes in bioinformatics solutions. The company has secured EUR 1.2 million in Series A funding on March 5, 2019, from Arches Capital, BOM Brabant Ventures, and NextGen Ventures. The founders are Alvise Trevisan and Nicola Bonzanni, with Paul van der Velde serving as CEO.ENPICOM specializes in bioinformatics solutions aimed at accelerating biologics discovery and engineering through its unified platform. The core offerings focus on providing a scalable data foundation, automating bioinformatics workflows, and integrating advanced machine learning frameworks specifically designed for lab, data, and ML scientists. The platform allows users to access extensive sequencing datasets and historical data efficiently, enhancing their ability to conduct complex queries on vast amounts of biological sequences. ENPICOM’s services are tailored to meet the needs of a diverse customer base that includes biopharmaceutical companies, research institutions, and organizations involved in vaccine development. These products are utilized primarily in North America, Europe, and Asia, addressing specific use cases such as candidate optimization, lead selection, and comprehensive analysis in biologics research.ENPICOM generates revenue through a combination of subscription-based models and service contracts tailored to clients’ specific needs within the biologics research sector. The business transactions are structured to facilitate continuous access to the platform's features, including advanced analysis workflows and model deployment functionalities, which support ongoing research efforts. Clients engage with ENPICOM on a B2B basis, typically entering into agreements that cover both software access and bespoke analytic services. The pricing framework includes plans that provide flexible access to the platform, enabling clients to leverage custom algorithms and perform extensive data queries. ENPICOM’s flagship services are designed to enhance collaboration between lab and data scientists, thereby driving efficiency and value in ongoing research activities.In March 2019, Enpicom BV raised EUR 1.2 million in Series A funding, which will be utilized to support ongoing development of new bioinformatics products and enhance their platform capabilities. The company is focused on expanding its services into new markets, particularly in Asia and North America, aiming for a broader rollout by 2023.

## Funding rounds

- Series A, Mar 5, 2019, $1.4M — NextGen Ventures, BOM Brabant Ventures, Arches Capital

## Investors

- NextGen Ventures — Series A
- BOM Brabant Ventures (https://capitalatlas.ai/funds/bom-brabant-ventures) — Series A
- Arches Capital (https://capitalatlas.ai/funds/arches-capital) — Series A